Burning Rock Biotech Limited
NASDAQ: BNR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Yusheng Han
- Employees
- 674
- Headquarters
- Guangzhou, China
- IPO year
- 2020
- Market cap
- $9.0M
- Website
- https://www.brbiotech.com
Loading BNR…
Loading profile data…Frequently asked questions about BNR
What does Burning Rock Biotech Limited (BNR) do?
Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the People's Republic of China. Its operations are structured across three key segments: Central Laboratory Business, In-Hospital Business, and Pharma R...
Where does BNR trade?
Burning Rock Biotech Limited (BNR) trades on the NASDAQ Global Market.
What sector is BNR in?
Burning Rock Biotech Limited (BNR) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Burning Rock Biotech Limited?
Yusheng Han is the chief executive officer of Burning Rock Biotech Limited (BNR).
Where is Burning Rock Biotech Limited headquartered?
Burning Rock Biotech Limited is headquartered in China.
Does BNR pay a dividend?
Burning Rock Biotech Limited (BNR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BNR go public?
Burning Rock Biotech Limited (BNR) completed its initial public offering in 2020.
Is BNR an ADR?
Yes — BNR is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Burning Rock Biotech Limited reporting and dividends follow the underlying issuer.